ALZHEIMER'S disease experts are revamping the way doctors diagnose patients with the progressive brain disorder - the most common type of dementia - by devising a seven-point rating scale based on cognitive and biological changes in the patient.
The proposed guidelines, unveiled by experts in a report issued at an Alzheimer's Association conference in Amsterdam, embrace a numerical staging system assessing disease progression similar to the one used in cancer diagnoses. They also eliminate the use of terms like mild, moderate and severe.
The revamp - replacing guidelines issued in 2018 - was prompted by the increased availability of tests detecting key Alzheimer's-related proteins such as beta amyloid in the blood and new treatments that require confirmation of disease pathology prior to use.
The new system is designed to be more accurate and better reflect a person's underlying disease, according to Dr. Clifford Jack of the Mayo Clinic in Rochester, Minnesota, lead author of the report sponsored by the Alzheimer's Association and the National Institute of Aging, a part of the U.S. government's National Institutes of Health.
The change comes at a time when doctors are preparing to identify and treat patients with Eisai and Biogen's drug Leqembi, which won Food and Drug Administration approval this month, and Eli Lilly's experimental drug donanemab, which is now under FDA review.
"We really are getting into an era of much more personalized medicine, where we're starting to understand that there are certain biomarkers that are elevated to certain degrees in people in different stages," said Dr. Maria Carrillo, chief scientific officer for the Alzheimer's Association.
Under the new diagnostic approach, patients would receive a score of 1 to 7 based on the presence of abnormal disease biomarkers and the extent of cognitive changes. The system also includes four biological stages ranked a, b, c and d. For example, Stage 1a is when a person is completely asymptomatic but has abnormal biomarkers.
"Stage 1a is really the beginning of evidence that someone has the disease," Jack said.
In Stage 2, an individual may have abnormal biomarkers and very subtle changes in cognition or behavior. Stage 3 is roughly equivalent to the current presymptomatic stage known as mild cognitive impairment, while stages 4, 5, and 6 are equivalent to mild, moderate and severe dementia.
The new scale also includes a Stage 0 for people who carry genes that guarantee they will develop Alzheimer's. This category includes people with Down Syndrome, 75% of whom develop Alzheimer's as adults.
Noting the new system's similarity to cancer stages, Jack said, "There's no such thing as mild breast cancer. They're numeric stages." Jack also noted that many other conditions can cause dementia but not all dementia is Alzheimer's disease.
The proposed guidelines are intended for doctors to use in clinical practice as many face the prospect for the first time of offering patients treatments that can slow the course of the disease, rather than just treat symptoms.
The draft guidelines are open for expert review and comment and will be revised later to reflect that input, according to a spokesperson for the Alzheimer's Association.
Alzheimer's, which gradually destroys memory and thinking skills, is characterized by changes in the brain including amyloid beta plaques and neurofibrillary, or tau, tangles that result in loss of neurons and their connections.
The 2018 guidelines, which were intended for research use, incorporated existing technologies for detecting Alzheimer's proteins based on PET scans of the brain and tests of cerebrospinal fluid, which were only accessible via a lumbar puncture. Such tests were costly and not typically used in standard medical practice.
Reuters
Sat Jul 29 2023
The new system is designed to be more accurate and better reflect a person's underlying disease, according to Dr. Clifford Jack of the Mayo Clinic in Rochester, Minnesota. - UNSPLASH/Filepic
Kelantan: 70 peratus kemalangan maut babit penunggang, pembonceng motosikal
70 peratus kes kemalangan maut yang dicatat berlaku dari 1 hingga 26 April di Kelantan, membabitkan penunggang dan pembonceng motosikal.
[TERKINI] WEF | Pembangunan dunia yang tidak seimbang, Apa Solusi?
Mesyuarat Khas Forum Ekonomi Dunia (WEF) di Arab Saudi merungkai masalah ekonomi dan ketidakseimbangan pembangunan yang sedang melanda dunia. Menteri MITI, Tengku Datuk Seri Zafrul Abdul Aziz dan Menteri Kewangan Arab Saudi, Mohammed Al-Jadaan berada sepentas merungkai masalah dunia yang memberi impak kepada semua negara.
PRK Kuala Kubu Baharu: Calon PH, PN bertembung ketika kempen
Dua calon yang bersaing bagi PRK Kuala Kubu Baharu hari ini bertembung buat kali pertama sejak hari penamaan calon semalam.
AWANI Ringkas: 1MDB - Polis Jerman rampas 4 kereta Bugatti Veyron edisi terhad
Ikuti rangkuman berita utama yang menjadi tumpuan sepanjang hari di Astro AWANI menerusi AWANI Ringkas.
Gempa bumi Indonesia, Tasikmalaya paling terjejas
Sekurang-kurangnya empat orang cedera dan 27 keluarga lagi terkesan selepas satu gempa bumi dengan magnitud 6.2 melanda Daerah Garut di Jawa Barat pada pukul 11.29 pagi waktu tempatan, Ahad.
Air penstabil dan pemangkin pembangunan negara - Fadillah Yusof
Air merupakan komponen penting yang bertindak sebagai penstabil dan pemangkin untuk pembangunan negara yang mampan.
Pelaburan RM2.4 bilion dibawa masuk ke Terengganu - MB
Sebanyak RM2.4 bilion nilai pelaburan yang berpotensi sedang dibawa masuk ke Terengganu setakat bulan April ini.
PRK Kuala Kubu Baharu: Kelayakan akademik bukan isu calon PN - Pas
Kempen PN sempena PRK Kuala Kubu Baharu tidak akan terjejas berikutan isu yang mengaitkan kelayakan akademik calonnya, Khairul Azhari Saut.
Peniaga nasi kukus raih jualan RM14,000 sebulan
Inisiatif Pendapatan Rakyat (IPR) mampu merubah graf pendapatan bulanan peserta apabila meningkatkan hasil jualan.
Piala Uber: Malaysia tewas kepada Taiwan
Malaysia memulakan kempen Kumpulan B Piala Uber 2024 mereka dengan langkah kiri apabila tewas 1-4 kepada Taiwan, di sini hari ini.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
Tony Bennett meninggal dunia pada usia 96 tahun
Penyanyi pop dan jazz popular yang memenangi 20 Anugerah Grammy, Tony Bennett meninggal dunia pada usia 96 tahun di New York, pada Jumaat.
FDA AS lulus ubat Leqembi untuk rawat Alzheimer
Leqembi berfungsi dengan mengurangkan amyloid plaques yang terbentuk di dalam otak, menurut FDA.
Pesakit Alzheimer di seluruh dunia mungkin cecah 139 juta menjelang 2050 - Laporan
Jumlah pesakit Alzheimer di dunia mungkin mencecah 139 juta menjelang 2050, menurut laporan terbaharu Pertubuhan Kesihatan Sedunia (WHO).
Isteri hidap Alzheimer turut dijangkiti COVID-19, Engelbert Humperdinck mohon doa peminat
Penyanyi balada terkenal Britain, Engelbert Humperdinck meminta peminat agar mendoakan kesihatan isterinya.
Hari Alzheimer Sedunia: KKM bangunkan Pelan Tindakan Demensia 2021-2030
Ketika ini KKM mengambil beberapa inisiatif dalam meningkatkan liputan rawatan dalam penjagaan geriatrik.
Pesakit Alzheimer perlu penjagaan rapi
Dengan peningkatan populasi warga emas, sistem sokongan dalam masyarakat perlu dipertingkatkan bagi membantu ahli keluarga yang menjaga warga emas yang menghidap Alzheimer.
Penghidap Alzheimer makin bertambah, Malaysia masih tiada Pelan Demensia Kebangsaan
Pelan Demensia Kebangsaan itu akan membantu 'generasi sandwich' iaitu golongan pertengahan usia yang mempunyai komitmen bukan sahaja membesarkan anak-anak tetapi juga menjaga ibu bapa mereka.
'Kawanku', peranti bantu warga emas nyanyuk
'Kawanku' berpotensi membantu warga emas menjalani aktiviti harian melalui maklumat dan arahan audio secara automatik.
Akibat ketagih, 'Pakcik Pokemon' luang 20 jam bawa 11 telefon keliling Taipei
Chen San-yuan, 70, mampu bermain Pokemon Go sehingga 20 jam tanpa henti menggunakan 11 telefon dan sembilan power bank yang dibawanya.